Literature DB >> 21982615

The utility of MRI for the surgical treatment of women with uterine fibroid tumors.

William H Parker1.   

Abstract

Determination of the reasonable treatment options and the appropriate clinical treatment of women with uterine fibroid tumors often depends on the ability of imaging modalities to accurately detect and localize fibroid tumors. Magnetic resonance imaging (MRI) gives the most complete evaluation (sizes, positions, number) of submucous, intramural, and subserosal myomas and is the most sensitive modality for the detection of small fibroid tumors. MRI allows the evaluation of fibroid tumor proximity to the bladder, rectum, and endometrial cavity, helps define what can be expected at surgery, and may help the gynecologist avoid missing fibroid tumors during surgery. MRI can also make the diagnosis of adenomyosis reliably and may be able to identify uterine sarcoma when present.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21982615     DOI: 10.1016/j.ajog.2011.08.021

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Postoperative outcomes after robotic versus abdominal myomectomy.

Authors:  Leanne Griffin; Joe Feinglass; Ariane Garrett; Anne Henson; Leeber Cohen; Angela Chaudhari; Alexander Lin
Journal:  JSLS       Date:  2013 Jul-Sep       Impact factor: 2.172

2.  Preoperative MRI and LDH in women undergoing intra-abdominal surgery for fibroids: Effect on surgical route.

Authors:  Annie Kim; Leslie Boyd; Nancy Ringel; Jessica Meyer; Genevieve Bennett; Veronica Lerner
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240

3.  Intraoperative Laparoscopic Ultrasound Increases Fibroid Detection During Laparoscopic Myomectomy.

Authors:  Hency H Patel; Dipti Banerjee; Kathryn Goldrath; Jeremy Chang; Megha D Tandel; Lorna Kwan; Steve Yu
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.